9-19 | In 2016, 50-year-old Shor Muluk embarked on a treacherous journey to Malaysia, fleeing violence against the Rohingya in Rakhine State, Myanmar. Leaving his wife and three children behind, he paid smugglers to transport him to Thailand. He spent seven days languishing on a crowded boat before being taken to a camp deep in the Thai mountains. There, Rohingya were beaten until their relatives sent the smugglers more money. Those whose families could not pay were killed, their bodies removed in the dead of night.
8-25 | Metun (name changed on request) is a Rohingya refugee in the Kutupalong-Balukhali megacamp in Cox’s Bazar, Bangladesh. He previously lived in Rakhine, Myanmar, working for NGOs there. He now volunteers with NGOs in the sprawling refugee camps in Cox’s Bazar. Here he shares his hopes and fears with MSF. “I’ve been in Bangladesh since 11 September 2017 – I remember the exact date we arrived. I fled with my wife and four children. We were always threatened in Rakhine.
8-14 | Sitting in a teashop in Kutupalong megacamp, Bibi Jan tugs on her sleeve. She’s covering up scars inflicted during the largest-ever episode of violence against the Rohingya, in August 2017. She tells us of the events that forced her to flee to Bangladesh: her two brothers were killed, she herself was stabbed, and her village was razed to the ground. A marginalised ethnic minority from Rakhine state, the Rohingya have in recent decades been subject to mounting targeted state exclusion and persecution.
6-12 | Médecins Sans Frontières (MSF) released findings from a follow-up survey of its community-based HIV/TB project in Eshowe, KwaZulu Natal.
11-29 | MSF criticises pharma for dragging feet on developing HIV drugs for children 1 December, 2018 is the 30th anniversary of World AIDS Day, ahead of a Vatican City meeting on scaling up HIV diagnosis and treatment for children, the international medical humanitarian organisation Médecins Sans Frontières (MSF) criticised pharmaceutical corporations for their delays and failure to develop appropriate formulations of HIV medicines for children.